Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Oct;33(10):2620–2623. doi: 10.1128/jcm.33.10.2620-2623.1995

Use of PCR and direct immunofluorescence microscopy for confirmation of results obtained by Syva MicroTrak Chlamydia enzyme immunoassay.

L Ostergaard 1, J K Møller 1
PMCID: PMC228542  PMID: 8567894

Abstract

A procedure for use of the Amplicor Chlamydia PCR with the Syva MicroTrak enzyme immunoassay (EIA) medium was developed, and the performance of the Syva MicroTrak EIA was evaluated by use of PCR and the Syva MicroTrak direct immunofluorescence assay (DFA) as confirmatory methods. PCR detected Chlamydia organisms at a 10-fold greater dilution than did DFA. Of 366 specimens, 119 specimens were positive by both PCR and DFA, 6 specimens were positive only by PCR, and 241 specimens were negative by both PCR and DFA. Subsequently, DFA and the developed PCR procedure were used prospectively for confirmation of EIA results in a defined negative gray zone between the cutoff value and 30% of the cutoff value (70% below the cutoff value). All specimens with results above the EIA cutoff value were also subjected to confirmation with DFA and PCR. EIA was performed on 7,748 endocervical swab specimens, of which 494 (6.4%) were subjected to confirmation, and on 968 male urethral swab specimens, of which 185 (19.1%) were subjected to confirmation. A "gold standard" was based on the findings by DFA and PCR, and divergent results were resolved by a major outer membrane protein-based PCR. Forty-five of 160 female specimens (28.1%) and 11 of 93 male specimens (11.8%) within the defined negative gray zone were found to be positive. Of 334 female specimens having absorbance unit (AU) values above the EIA cutoff value, 258 could be confirmed, thereby giving a positive predictive value of 77% (258/334). Accordingly, the positive predictive value with male specimens was 95% (87/92). The prevalence of Chlamydia trachomatis-positive specimens was 3.9% (303/7,748) in females and 10.1% (98/968) in males.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (182.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beebe J. L., Rau M. P., Albrecht K. D. Confirmatory testing of Chlamydia trachomatis Syva enzyme immunoassay gray zone specimens by Syva direct fluorescent antibody test. Sex Transm Dis. 1993 May-Jun;20(3):140–142. doi: 10.1097/00007435-199305000-00004. [DOI] [PubMed] [Google Scholar]
  2. Chan E. L., Brandt K., Horsman G. B. A 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory. J Clin Microbiol. 1994 Sep;32(9):2208–2211. doi: 10.1128/jcm.32.9.2208-2211.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke L. M., Sierra M. F., Daidone B. J., Lopez N., Covino J. M., McCormack W. M. Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol. 1993 Apr;31(4):968–971. doi: 10.1128/jcm.31.4.968-971.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Domeika M., Bassiri M., Mårdh P. A. Diagnosis of genital Chlamydia trachomatis infections in asymptomatic males by testing urine by PCR. J Clin Microbiol. 1994 Oct;32(10):2350–2352. doi: 10.1128/jcm.32.10.2350-2352.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jaschek G., Gaydos C. A., Welsh L. E., Quinn T. C. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol. 1993 May;31(5):1209–1212. doi: 10.1128/jcm.31.5.1209-1212.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lin J. S., Jones W. E., Yan L., Wirthwein K. A., Flaherty E. E., Haivanis R. M., Rice P. A. Underdiagnosis of Chlamydia trachomatis infection. Diagnostic limitations in patients with low-level infection. Sex Transm Dis. 1992 Sep-Oct;19(5):259–265. doi: 10.1097/00007435-199209000-00004. [DOI] [PubMed] [Google Scholar]
  7. Mahony J. B., Luinstra K. E., Sellors J. W., Jang D., Chernesky M. A. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men. J Clin Microbiol. 1992 Sep;30(9):2241–2245. doi: 10.1128/jcm.30.9.2241-2245.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ostergaard L., Birkelund S., Christiansen G. Use of polymerase chain reaction for detection of Chlamydia trachomatis. J Clin Microbiol. 1990 Jun;28(6):1254–1260. doi: 10.1128/jcm.28.6.1254-1260.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ostergaard L. Detection of Chlamydia trachomatis in a low prevalence population. Eur J Clin Microbiol Infect Dis. 1995 May;14(5):471–472. doi: 10.1007/BF02114911. [DOI] [PubMed] [Google Scholar]
  10. Ostergaard L., Lundemose A. G., Birkelund S., Christiansen G. Age and sex correlation of Chlamydia trachomatis infections evaluated by the culture technique and by an enzyme immunosorbent assay, IDEIA. Eur J Obstet Gynecol Reprod Biol. 1990 Mar;34(3):273–281. doi: 10.1016/0028-2243(90)90081-b. [DOI] [PubMed] [Google Scholar]
  11. Palmer L., Falkow S. A common plasmid of Chlamydia trachomatis. Plasmid. 1986 Jul;16(1):52–62. doi: 10.1016/0147-619x(86)90079-x. [DOI] [PubMed] [Google Scholar]
  12. Peterson E. M., Markoff B. A., Schachter J., de la Maza L. M. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid. 1990 Mar;23(2):144–148. doi: 10.1016/0147-619x(90)90033-9. [DOI] [PubMed] [Google Scholar]
  13. Thejls H., Gnarpe J., Gnarpe H., Larsson P. G., Platz-Christensen J. J., Ostergaard L., Victor A. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med. 1994 Oct;70(5):300–303. doi: 10.1136/sti.70.5.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thomas B. J., MacLeod E. J., Hay P. E., Horner P. J., Taylor-Robinson D. Limited value of two widely used enzyme immunoassays for detection of Chlamydia trachomatis in women. Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):651–655. doi: 10.1007/BF01973991. [DOI] [PubMed] [Google Scholar]
  15. Zeeberg B., Thelin I., Schalén C. Chlamydia trachomatis antigen detection by Chlamydiazyme combined with Chlamydia Blocking Reagent verification. Int J STD AIDS. 1992 Sep-Oct;3(5):355–359. doi: 10.1177/095646249200300510. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES